Dr. Martens has reported resilient Q3 FY26 trading despite a tough retail backdrop, with revenue down 2.7 per cent to £253 million (~$346.6 million) due to tighter promotions.
YTD revenue slipped 0.7 per cent.
Wholesale outperformed, while DTC declined amid a focus on full-price sales.
The Americas led growth.
The company expects flat FY26 revenue and strong YoY PBT growth.Dr. Martens has reported resilient Q3 FY26 trading despite a tough retail backdrop, with revenue down 2.7 per cent to £253 million (~$346.6 million) due to tighter promotions.
YTD revenue slipped 0.7 per cent.
Wholesale outperformed, while DTC declined amid a focus on full-price sales.
The Americas led growth.
The company expects flat FY26 revenue and strong YoY PBT growth.
